Blood Flow Restriction Training for Knee Instability
(BRAINS Trial)
Trial Summary
What is the purpose of this trial?
This trial is testing whether using an air cuff to limit blood flow during physical therapy helps people with unstable kneecaps recover faster. Patients will receive either regular physical therapy or regular therapy plus this new method. The goal is to see if this approach helps muscles get stronger more quickly.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, if you have diabetes or uncontrolled hypertension, you are not eligible to participate.
What data supports the effectiveness of the treatment Blood Flow Restriction Training for knee instability?
Research shows that Blood Flow Restriction Training (BFRT) can help improve knee strength and reduce muscle loss in various knee conditions, such as after knee surgery or in knee osteoarthritis. It has also been found to decrease knee pain more effectively than regular resistance training alone.12345
Is Blood Flow Restriction Training generally safe for humans?
How is Blood Flow Restriction Training different from other treatments for knee instability?
Blood Flow Restriction Training (BFRT) is unique because it uses a cuff to partially restrict blood flow, allowing for muscle strengthening with lighter weights, which is beneficial for those who cannot handle heavy loads after knee surgery or injury. This approach can help reduce muscle loss and improve strength more effectively than traditional heavy strength training, especially in early rehabilitation stages.24578
Research Team
Caitlin Conley, PhD
Principal Investigator
University of Kentucky
Eligibility Criteria
This trial is for individuals aged 14-40 with closed growth plates and traumatic patellar instability, who are active in sports like tennis or skiing at least once a week. They must want to return to their pre-injury activity level. Excluded are those with certain knee conditions, surgeries, high BMI (>35), varicose veins, history of deep vein thrombosis in the family, planned long absences during the trial period, diabetes or uncontrolled hypertension.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo 8 weeks of either standard physical therapy or standard physical therapy with blood flow restriction training (BFRT).
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments of knee and hip strength, biomechanics, and MRI evaluations.
Treatment Details
Interventions
- Blood Flow Restriction Training (Behavioural Intervention)
Blood Flow Restriction Training is already approved in Japan for the following indications:
- Muscle strengthening and hypertrophy
- Rehabilitation after injuries
- Improving muscle endurance
Find a Clinic Near You
Who Is Running the Clinical Trial?
Caitin Conley
Lead Sponsor
Cale Jacobs, PhD
Lead Sponsor
Caitlin Conley
Lead Sponsor
The Cleveland Clinic
Collaborator
David Peter
The Cleveland Clinic
Chief Medical Officer
MD, board-certified in Hospice and Palliative Medicine
Tomislav Mihaljevic
The Cleveland Clinic
Chief Executive Officer since 2018
MD from University of Zagreb School of Medicine